mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
8e-09 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-06 |